1-7 of 7
Yangzhi Zhao
Close
Sort by
Journal Articles

A Multicenter, Prospective Clinical Study of the R-CDOP Regimen in Previously Untreated Non-Hodgkin Lymphoma with High Tumor Burden

Wei Guo, Xingtong Wang, Yangzhi Zhao, Jia Li, Chunshui Liu, Xin Wan, Ou Bai
Journal: Blood
Blood (2023) 142 (Supplement 1): 1736.
https://doi.org/10.1182/blood-2023-188580
Published: 2023
Journal Articles

A Retrospective Analysis on the Efficacy and Saftey of Obinutuzumab in the Treatment of Non-Hodgkin B Cell Lymphoma

Yangzhi Zhao, Wei Guo, Jia Li, Xingtong Wang, Xin Wan, Junna Li, Ou Bai
Journal: Blood
Blood (2023) 142 (Supplement 1): 4427.
https://doi.org/10.1182/blood-2023-187801
Published: 2023
Journal Articles

Lenalidomide in Combination with Etoposide Induced Ferroptotic Cell Death in DLBCL

Jia Li, Wei Guo, Yangzhi Zhao, Xingtong Wang, Xin Wan, Ou Bai
Journal: Blood
Blood (2023) 142 (Supplement 1): 5788.
https://doi.org/10.1182/blood-2023-186912
Published: 2023
Journal Articles

The Combination of Pegfilgrastim and Filgrastim Improves the Outcomes of Mobilization and Engraftment after Transplantation of Autologous Hematopoietic Stem Cells for the Treatment of Lymphoma

Xingtong Wang, Wei Guo, Yangzhi Zhao, Jia Li, Xin Wan, Ou Bai
Journal: Blood
Blood (2023) 142 (Supplement 1): 4891.
https://doi.org/10.1182/blood-2023-182840
Published: 2023
Journal Articles

The Short-Term Efficacy and Safety of Obinutuzumab Plus Chemotherapy in B-NHL with High Tumor Burden: A Real-World, Retrospective Study

Xin Wan, Wei Guo, Xingtong Wang, Yangzhi Zhao, Jia Li, Junna Li, Zhumei Zhan, Ou Bai
Journal: Blood
Blood (2022) 140 (Supplement 1): 11977–11978.
https://doi.org/10.1182/blood-2022-169343
Published: 2022
Journal Articles

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Wei Guo, Yangzhi Zhao, Xingtong Wang, Jia Li, Qiang Guo, Junna Li, Ken H. Young, Ou Bai
Journal: Blood
Blood (2021) 138 (Supplement 1): 2442.
https://doi.org/10.1182/blood-2021-152164
Published: 2021
Journal Articles

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Wei Guo, Xiaomeng Feng, Yinping Wang, Jia Li, Yangzhi Zhao, Limei Qu, Xu Yan, Junna Li, Qiang Guo, Ken H. Young, Ou Bai
Journal: Blood
Blood (2021) 138 (Supplement 1): 4563.
https://doi.org/10.1182/blood-2021-147695
Published: 2021